Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma
- 25 July 2016
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (10) , 13167-13176
Abstract
The spliceosome machinery composed of multimeric protein complexes guides precursor messenger RNAs (mRNAs) (pre-mRNAs) splicing in eukaryotic cells. Spliceosome components have been shown to be downregulated in cancer and could be a promising molecular target for anticancer therapy. The ubiquitin-specific protease 39 (USP39) is essential for pre-mRNA splicing, and upregulated USP39 expression is noted in a variety of cancers. However, the role of USP39 in the development and progression of melanoma remains unclear. In the present study, USP39 expression was found to be increased in melanoma tissues compared with that in nevus tissues. USP39 silencing via lentivirus-mediated short hairpin RNA (shRNA) significantly suppressed melanoma cell proliferation, induced G0/G1 cell cycle phase arrest, and increased apoptosis in vitro. Moreover, USP39 knockdown suppressed melanoma tumor growth in a xenograft model. In addition, USP39 silencing was associated with the increased expressions of p21, p27, and Bax. Furthermore, the inhibition of USP39 expression decreased the phosphorylation of extracellular signal-regulated kinase (ERK)1/2, indicating that ERK signaling pathways might be involved in the regulation of melanoma cell proliferation by USP39. Our findings suggest that USP39 may play crucial roles in the development and pathogenesis of melanoma, and it may serve as a potential therapeutic target for melanoma.Keywords
This publication has 40 references indexed in Scilit:
- Overexpression of TROP2 Predicts Poor Prognosis of Patients with Cervical Cancer and Promotes the Proliferation and Invasion of Cervical Cancer Cells by Regulating ERK Signaling PathwayPLOS ONE, 2013
- Functional roles of protein splicing factorsBioscience Reports, 2012
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2011
- Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractorinessBlood, 2011
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesNature Genetics, 2011
- Zebrafish usp39 Mutation Leads to rb1 mRNA Splicing Defect and Pituitary Lineage ExpansionPLOS Genetics, 2011
- Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora BCell Cycle, 2008
- Aberrant RNA splicing and its functional consequences in cancer cellsDisease Models & Mechanisms, 2008
- CDK Inhibitors: Cell Cycle Regulators and BeyondDevelopmental Cell, 2008